Intervention1: Genotyping and TDM: Use of genotyping and TDM as a strategy for risk minimization will be evaluated in two groups of patients those in which genotyping and TDM both will be done and tho

2 trials

Sponsors

Dr Nithya Gogtay

Conditions

Health Condition 1: G403- Generalized idiopathic epilepsy and epileptic syndromes

Unknown Phase

Genotyping and TDM in Epileptic patients on CBZ : RCT

Active, not recruitingCTRI/2019/09/021311

Dr Nithya GogtayHealth Condition 1: G403- Generalized idiopathic epilepsy and epileptic syndromes

Target: 50Updated: 2023-07-25

Genotyping and Therapeutic Drug Monitoring in Epileptic patients on Phenytoin : RCT

Active, not recruitingCTRI/2019/09/021317

Dr Nithya GogtayHealth Condition 1: G403- Generalized idiopathic epilepsy and epileptic syndromes

Target: 50Updated: 2023-05-29